Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
R03BA08 CICLESONIDUM SOL. DE INHALAT 160 µg/doză
PRESURIZATĂ
ALVESCO 160 INHALER 160 µg/doză ALTANA PHARMA AG
R03BA08 CICLESONIDUM SOL. DE INHALAT 80 µg/doză
PRESURIZATĂ
ALVESCO 80 INHALER 80 µg/doză ALTANA PHARMA AG
________________________________________________________________________________
______________________________________________________________________________
| 353 |R03BB04| TIOTROPIUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03BB04 TIOTROPIUM CAPS. CU PULB. INHAL. 18 µg
SPIRIVA(R) 18 µg 18 µg BOEHRINGER INGELHEIM
PHARMA GMBH & CO.KG
Prescriere limitată: Pentru tratamentul de întreţinere pe termen lung al bronhospasmului şi dispneei asociate bolii pulmonare obstructive cronice
________________________________________________________________________________
______________________________________________________________________________
| 354 |R03DA05| AMINOPHYLLINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03DA05 AMINOPHYLLINUM CAPS. 100 mg
MIOFILIN 100 mg 100 mg ZENTIVA SA
R03DA05 AMINOPHYLLINUM COMPR. 100 mg
AMINOFILINA EEL 100 mg BIO EEL SRL
R03DA05 AMINOPHYLLINUM COMPR. 200 mg
AMINOFILINA 200 mg 200 mg ARENA GROUP SA
R03DA05 AMINOPHYLLINUM SOL. INJ. 24 mg/ml
MIOFILIN 24 mg/ml ZENTIVA S.A.
________________________________________________________________________________
______________________________________________________________________________
| 355 |R03DC03| MONTELUKASTUM* | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03DC03 MONTELUKASTUM COMPR. FILM. 10 mg
SINGULAIR(R) 10 mg MERCK SHARP & DOHME
ROMANIA S.R.L.
Prescriere limitată: Tratamentul combinat al astmului bronşic persistent la pacienţii cu simptomatologie necontrolată corespunzător cu corticosteroizi inhalatori şi beta-2-agonişti cu durată scurtă de acţiune.
R03DC03 MONTELUKASTUM COMPR. MAST. 4 mg
SINGULAIR 4 mg MERCK SHARP & DOHME S.R.L.
Prescriere limitată: Tratamentul combinat al astmului bronşic persistent la pacienţii cu simptomatologie necontrolată corespunzător cu corticosteroizi inhalatori şi beta-2-agonişti cu durată scurtă de acţiune.
Cod restricţie 2617: Tratamentul astmului bronşic persistent la copii cu vârste cuprinse între 2 şi 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.
R03DC03 MONTELUKASTUM GRANULE 4 mg/plic
SINGULAIR(R) 4 mg/plic MERCK SHARP & DOHME
ROMANIA S.R.L.
Prescriere limitată: Tratamentul combinat al astmului bronşic persistent la pacienţii cu simptomatologie necontrolată corespunzător cu corticosteroizi inhalatori şi beta-2-agonişti cu durată scurtă de acţiune.
Cod restricţie 2617: Tratamentul astmului bronşic persistent la copii cu vârste cuprinse între 2 şi 5 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.
R03DC03 MONTELUKASTUM COMPR. MAST. 5 mg
SINGULAIR(R) 5 mg MERCK SHARP & DOHME
ROMANIA S.R.L.
Prescriere limitată: Tratamentul combinat al astmului bronşic persistent la pacienţii cu simptomatologie necontrolată corespunzător cu corticosteroizi inhalatori şi beta-2-agonişti cu durată scurtă de acţiune.
Cod restricţie 2617: Tratamentul astmului bronşic persistent la copii cu vârste cuprinse între 6 şi 14 ani la care nu se poate administra terapie cu corticosteroizi inhalatori.
________________________________________________________________________________
______________________________________________________________________________
| 356 |R03DX03| FENSPIRIDUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R03DX03 FENSPIRIDUM SIROP 0.2%
EURESPAL(R) 0.2% LES LAB. SERVIER IND.
R03DX03 FENSPIRIDUM COMPR. FILM. 80 mg
EURESPAL 80 mg 80 mg LES LAB. SERVIER IND.
________________________________________________________________________________
______________________________________________________________________________
| 357 |R05CB15| ERDOSTEINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R05CB15 ERDOSTEINUM PULB. PT. SUSP. ORALĂ 175 mg/5 ml
ERDOMED(R) 175 175 mg/5 ml CSC PHARMACEUTICALS
HANDELS GMBH
R05CB15 ERDOSTEINUM CAPS. 300 mg
ERDOMED 300 mg MEDICOM INTERNATIONAL SRO
________________________________________________________________________________
______________________________________________________________________________
| 358 |R05DA09| DEXTROMETHORPHANUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R05DA09 DEXTROMETHORPHANUM SIROP 0.1%
HUMEX 0.1% LAB. URGO SA
TUSSIN SIROP 0.1% GLOBAL PHARMACEUTICALS
S.R.L.
R05DA09 DEXTROMETHORPHANUM SIROP 0.13%
HUMEX 0.13% LAB. URGO SA
R05DA09 DEXTROMETHORPHANUM COMPR. 10 mg
TUSSIN 10 mg EUROPHARM SA
R05DA09 DEXTROMETHORPHANUM SIROP 15 mg/5 ml
ROFEDEX 15 mg/5 ml BIOFARM SA
R05DA09 DEXTROMETHORPHANUM COMPR. 20 mg
TUSSIN FORTE 20 mg EUROPHARM SA
R05DA09 DEXTROMETHORPHANUM SOL. ORALĂ 3.75 mg/5 ml
ROBITUSSIN JUNIOR 3.75 mg/5 ml WYETH WHITEHALL EXPORT
GMBH
R05DA09 DEXTROMETHORPHANUM SOL. ORALĂ 7.5 mg/5 ml
ROBITUSSIN ANTITUSSICUM 7.5 mg/5 ml WYETH WHITEHALL EXPORT
GMBH
________________________________________________________________________________
______________________________________________________________________________
| 359 |R06AE09| LEVOCETIRIZINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AE09 LEVOCETIRIZINUM COMPR. FILM. 5 mg
XYZAL(R) 5 mg U.C.B. GMBH
R06AE09 LEVOCETIRIZINUM PIC. ORALE, SOL. 5 mg/ml
XYZAL 5 mg/ml U.C.B. GMBH
________________________________________________________________________________
______________________________________________________________________________
| 360 |R06AX26| FEXOFENADINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AX26 FEXOFENADINUM COMPR. FILM. 120 mg
ALTIVA 120 mg 120 mg RANBAXY UK LTD.
TELFAST(R) 120 mg 120 mg AVENTIS PHARMA DEUTSCHLAND
GMBH
R06AX26 FEXOFENADINUM COMPR. FILM. 180 mg
ALTIVA 180 mg 180 mg RANBAXY UK LTD.
TELFAST(R) 180 mg 180 mg AVENTIS PHARMA DEUTSCHLAND
GMBH
R06AX26 FEXOFENADINUM COMPR. FILM. 30 mg
TELFAST(R) 30 mg 30 mg AVENTIS PHARMA DEUTSCHLAND
GMBH
________________________________________________________________________________
______________________________________________________________________________
| 361 |R06AX27| DESLORATADINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
R06AX27 DESLORATADINUM SIROP 0.5 mg/ml
AERIUS 0.5 mg/ml 0.5 mg/ml SP EUROPE
R06AX27 DESLORATADINUM COMPR. FILM. 5 mg
AERIUS 5 mg 5 mg SP EUROPE
________________________________________________________________________________
______________________________________________________________________________
| 362 |S01AA11| GENTAMICINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01AA11 GENTAMICINUM PICĂTURI OFT. - SOL. 0.3%
OPHTAGRAM(R) 0,3% 0.3% LAB. CHAUVIN
S01AA11 GENTAMICINUM SOL. OFT. 0.3%
GENTICOL 0.3% S.I.F.I. SPA
S01AA11 GENTAMICINUM UNG. OFT. 0.3%
GENTICOL 0.3% S.I.F.I. SPA
OPHTAGRAM(R) 0,3% 0.3% LAB. CHAUVIN
S01AA11 GENTAMICINUM PIC. OFT., SOL. 0.3%
GENTAMICIN SULPHATE 0.3% E.I.P.I.CO. MED S.R.L.
________________________________________________________________________________
______________________________________________________________________________
| 363 |S01AA12| TOBRAMYCINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01AA12 TOBRAMYCINUM UNG. OFT. 0.3%
TOBREX(R) 0.3% ALCON COUVREUR NV
S01AA12 TOBRAMYCINUM PIC. OFT., SOL. 0.3%
TOBISOL 0.3% E.I.P.I.CO. MED S.R.L.
S01AA12 TOBRAMYCINUM PIC. OFT., SOL. 3 mg/ml
TOBREX 3 mg/ml ALCON COUVREUR NV
________________________________________________________________________________
______________________________________________________________________________
| 364 |S01AA23| NETILMICINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01AA23 NETILMICINUM PICĂTURI OFT. - SOL. 0.3%
NETTACIN(R) 0.3% S.I.F.I. SPA
S01AA23 NETILMICINUM UNG. OFT. 3 mg/g
NETTAVISC 3 mg/g 3 mg/g S.I.F.I. SPA
S01AA23 NETILMICINUM PIC. OFT., SOL. 0.3%
NETTACIN(R) 0.3% S.I.F.I. SPA
________________________________________________________________________________
______________________________________________________________________________
| 365 |S01AX11| OFLOXACINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01AX11 OFLOXACINUM PICĂTURI OFT. - SOL. 0.3%
FLOXAL(R) 0.3% DR. GERHARD MANN
CHEM-PHARM. FABRIK GMBH
S01AX11 OFLOXACINUM UNG. OFT. 0.3%
FLOXAL(R) 0.3% DR. GERHARD MANN
CHEM-PHARM. FABRIK GMBH
________________________________________________________________________________
______________________________________________________________________________
| 366 |S01BA01| DEXAMETHASONUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01BA01 DEXAMETHASONUM PICĂTURI OFT. - SUSP. 0.1%
MAXIDEX(R) 0.1% ALCON COUVREUR NV
________________________________________________________________________________
______________________________________________________________________________
| 367 |S01BA06| BETAMETHASONUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01BA06 BETAMETHASONUM SOL. OFT. 0.1%
OPHTAMESONE 0.1% DAR AL DAWA PHARMA S.R.L.
________________________________________________________________________________
______________________________________________________________________________
| 368 |S01CA01| COMBINAŢII (NETILMICINUM + DEXAMETHASONUM) | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01CA01 COMBINAŢII PIC. OFT., SOL.
(NETILMICINUM +
DEXAMETHASONUM)
NETILDEX S.I.F.I. SPA
S01CA01 COMBINAŢII PIC. OFT. SOL. UNIDOZĂ
(NETILMICINUM +
DEXAMETHASONUM)
NETILDEX S.I.F.I. SPA
________________________________________________________________________________
______________________________________________________________________________
| 369 |S01CA01| COMBINAŢII (TOBRAMYCINUM + DEXAMETHASONUM) | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01CA01 COMBINAŢII UNG. OFT. 1 mg + 3 mg
(TOBRAMYCINUM +
DEXAMETHASONUM)
TOBRADEX(R) 1 mg + 3 mg ALCON COUVREUR NV
S01CA01 COMBINAŢII PICĂTURI OFT. - SUSP. 1 mg + 3 mg
(TOBRAMYCINUM +
DEXAMETHASONUM)
TOBRADEX(R) 1 mg + 3 mg ALCON COUVREUR NV
________________________________________________________________________________
______________________________________________________________________________
| 370 |S01CA01| COMBINAŢII (CHLORAMPHENICOLUM + | |
| | | DEXAMETHASONUM)| | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01CA01 COMBINAŢII PICĂTURI OFT. - SOL. 5 mg/ml + 1 mg/ml
(CHLORAMPHENICOLUM +
DEXAMETHASONUM)
SPERSADEX COMP 5 mg/ml + 1 mg/ml NOVARTIS PHARMA GMBH
________________________________________________________________________________
______________________________________________________________________________
| 371 |S01GX09| OLOPATADINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01GX09 OLOPATADINUM PIC. OFT., SOL. 1 mg/ml
OPATANOL 1 mg/ml 1 mg/ml ALCON LABORATORIES LTD.
________________________________________________________________________________
______________________________________________________________________________
| 372 |S01XA02| RETINOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
S01XA02 RETINOLUM GEL OFT. 10 mg/g
OCULOTECT 10 mg/g NOVARTIS PHARMA GMBH
________________________________________________________________________________
______________________________________________________________________________
| 1219 |H03BB01| CARBIMAZOLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
H03BB01 CARBIMAZOLUM COMPR. FILM. 5 mg
CARBIMAZOLE 5 5 mg REMEDICA LTD.
________________________________________________________________________________
SUBLISTA C1 - G1 INSUFICIENŢA CARDIACĂ CRONICĂ (CLASA III SAU IV NYHA).
______________________________________________________________________________
| 373 |B01AA07| ACENOCUMAROLUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
B01AA07 ACENOCUMAROLUM COMPR. 2 mg
TROMBOSTOP 2 mg 2 mg TERAPIA SA
B01AA07 ACENOCUMAROLUM COMPR. 4 mg
SINTROM(R) 4 mg NOVARTIS PHARMA GMBH
________________________________________________________________________________
______________________________________________________________________________
| 374 |C01AA05| DIGOXINUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
C01AA05 DIGOXINUM SOL. ORALĂ 0.05 mg/ml
LANOXIN SOLUŢIE ORALĂ 0.05 mg/ml THE WELLCOME FOUNDATION
LTD.
C01AA05 DIGOXINUM COMPR. 0.25 mg
DIGOXIN 0.25 mg 0.25 mg ZENTIVA S.A.
C01AA05 DIGOXINUM SOL. INJ. 0.5 mg/ml
DIGOXIN 0.5 mg/2 ml 0.5 mg/ml ZENTIVA S.A.
________________________________________________________________________________
______________________________________________________________________________
| 375 |C03AA03| HYDROCHLOROTHIAZIDUM | |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
C03AA03 HYDROCHLOROTHIAZIDUM COMPR. 25 mg
NEFRIX 25 mg 25 mg ZENTIVA SA
________________________________________________________________________________
______________________________________________________________________________
| 376 |C03CA01| FUROSEMIDUM | |
|_______|_______|____________________________________________|_________________|
Electroliţii serici trebuie să fie verificaţi periodic.
Dostları ilə paylaş: |